Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот документ:
https://elib.bsu.by/handle/123456789/289409
Заглавие документа: | Complex-dependent histone acetyltransferase activity of KAT8 determines its role in transcription and cellular homeostasis |
Авторы: | Radzisheuskaya, Aliaksandra Shliaha, Pavel V. Grinev, Vasily V. Shlyueva, Daria Damhofer, Helene Koche, Richard Gorshkov, Vladimir Kovalchuk, Sergey Zhan, Yingqian Rodriguez, Keli L. Johnstone, Andrea L. Keogh, Michael-C Hendrickson, Ronald C. Jensen, Ole N. Helin, Kristian |
Тема: | ЭБ БГУ::ЕСТЕСТВЕННЫЕ И ТОЧНЫЕ НАУКИ::Биология |
Дата публикации: | 2021 |
Издатель: | Cell Press |
Библиографическое описание источника: | Mol Cell 2021;81(8):1749-1765.e8. |
Аннотация: | Acetylation of lysine 16 on histone H4 (H4K16ac) is catalyzed by histone acetyltransferase KAT8 and can prevent chromatin compaction in vitro. Although extensively studied in Drosophila, the functions of H4K16ac and two KAT8-containing protein complexes (NSL and MSL) are not well understood in mammals. Here, we demonstrate a surprising complex-dependent activity of KAT8: it catalyzes H4K5ac and H4K8ac as part of the NSL complex, whereas it catalyzes the bulk of H4K16ac as part of the MSL complex. Furthermore, we show that MSL complex proteins and H4K16ac are not required for cell proliferation and chromatin accessibility, whereas the NSL complex is essential for cell survival, as it stimulates transcription initiation at the promoters of housekeeping genes. In summary, we show that KAT8 switches catalytic activity and function depending on its associated proteins and that, when in the NSL complex, it catalyzes H4K5ac and H4K8ac required for the expression of essential genes. |
URI документа: | https://elib.bsu.by/handle/123456789/289409 |
DOI документа: | 10.1016/j.molcel.2021.02.012 |
Scopus идентификатор документа: | 85103297674 |
Финансовая поддержка: | We thank members of the Helin laboratory for discussions; Robin Armstrong for critical reading of the manuscript; Sarah Teed, Abbas Nazir, Eugenia Lorenzini, Charlotte Holck, and Zhifan Yang for technical assistance; Zuo-Fei Yuan for epiProfile software support; Jedd Wolchok's lab for SKMEL28 cells; Joshua Brickman's lab for E14 mouse ESCs; and Xuejun Jiang's lab for HeLa and U2OS cells. A.R. and D.S. were in part funded by the European Union's Horizon 2020 research and innovation program under Marie Skłodowska-Curie grant agreements 659171 and 749362, respectively. The work in the Helin laboratory was supported by the Danish Cancer Society (R167-A10877), through a center grant from the Novo Nordisk Foundation (NNF) to the NNF Center for Stem Cell Biology (NNF17CC0027852), and through the Memorial Sloan Kettering Cancer Center Support Grant (NIH P30 CA008748). Studies in EpiCypher were funded by the NIH (R44 CA212733, R44 GM136172, R44 HG008907, and R44 GM116584). Experimental and computational proteomics work at the University of Southern Denmark (SDU) (P.V.S. V.G. S.K. and O.N.J.) was supported by the research infrastructure provided by the Danish National Mass Spectrometry Platform for Functional Proteomics (PRO-MS; 5072-00007B) and the VILLUM Center for Bioanalytical Sciences (7292). P.V.S. was supported by a postdoctoral fellowship from the Lundbeck Foundation (R231-2016-3093). S.K. was supported by a research grant from Independent Research Fund Denmark (to O.N.J. 4181-00172B). Research in the V.V.G. laboratory was supported in part by the Ministry of Education of the Republic of Belarus (grant 3.08.3 [469/54]). Conceptualization, A.R. and K.H.; Methodology, A.R. and P.V.S.; Investigation, A.R. P.V.S. V.V.G. D.S. H.D. R.K. V.G. S.K. Y.Z. K.L.R. A.L.J. and M.-C.K.; Writing – Original Draft, A.R. and K.H.; Writing – Review & Editing, all authors; Visualization, A.R. and V.V.G.; Funding Acquisition, A.R. P.V.S. O.N.J. and K.H.; Supervision, R.C.H. O.N.J. and K.H. EpiCypher is a commercial developer and supplier of reagents (recombinant semi-synthetic modified nucleosomes) and the antibody characterization platforms used in this study. K.H. is a consultant for Inthera Bioscience AG and a scientific advisor for Hannibal Health Innovation. |
Лицензия: | info:eu-repo/semantics/openAccess |
Располагается в коллекциях: | Статьи биологического факультета |
Полный текст документа:
Файл | Описание | Размер | Формат | |
---|---|---|---|---|
1-s2.0-S1097276521000988-main.pdf | 5,13 MB | Adobe PDF | Открыть |
Все документы в Электронной библиотеке защищены авторским правом, все права сохранены.